関連する実験動画
Updated: May 3, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
34.4K
2型炎症による重度の喘息の生物学的治療法:現在のエビデンス,患者の選択,および将来の展望
1Department of Intellectual property Rights, Research and Development cell, Lovely Professional University, Jalandhar - Delhi Grand Trunk Rd, Phagwara, Punjab 144411, India.
まとめ
生物学的治療法は,特定の免疫経路を標的として,重度のアレルギー性喘息の治療に革命的なアプローチを提供します. バイオマーカーを用いたパーソナライズされた治療は結果を改善しますが,これらの先進的な薬のアクセシビリティとコストは依然として課題です.
科学分野:
- 免疫学と肺学について
- 薬理学と治療革新
背景:
- アレルギー性喘息の管理は,生物学的治療法によって変化しました.
- これらの治療は,患者のアウトカムを改善するために,特定の免疫調節をターゲットにします.
研究 の 目的:
- 重度のアレルギー性喘息の生物学的治療法に関する現在の臨床的証拠を合成する.
- 患者の選択基準,安全性,および将来の方向性を調査する.
主な方法:
- 2025年まで,PubMed,Embase,およびCochraneの体系的な文献検索を行いました.
- IGEと2型炎症を標的とする生物学的薬に関するランダム化比較試験,メタ解析,現実世界の研究を優先する.
主要な成果:
- 生物学的な薬は,喘息の悪化,入院,およびコルチコステロイドの使用を大幅に軽減します.
- エオシノフィルの数,IgE,FeNOなどのバイオマーカーは,治療応答を最適化します.
- 課題には,コスト,アクセシビリティ,長期的な安全データなどがあります.
結論:
- 2型炎症を標的とする生物学的剤は,アレルギー性喘息のケアにおけるパラダイムシフトである.
- パーソナライズド医療のアプローチは,臨床上の利点を強化し,最適化のためのさらなる研究を必要とします.
関連する概念動画
Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

